Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04778839 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.

StatusUnknown
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 6, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
  2. Primary completion date: Oct 31, 2024 to Jun 30, 2026
    • Study completion date: Dec 31, 2024 to Jun 30, 2026
    v4
  3. Primary completion date: Mar 1, 2023 to Oct 31, 2024
    • Study completion date: Mar 1, 2023 to Dec 31, 2024
    v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 1, 2021 to Mar 4, 2021
    • Site details revised
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A Phase I Study of Dose Escalation and Dose Expansion To Evaluate the Safety、Tolerability、Pharmacokinetics and Preliminary Efficacy of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumor.
Trial Details
NCT Number NCT04778839
Lead Sponsor First Affiliated Hospital of Zhejiang University
Collaborators: Hangzhou Dihua Biotechnology Co., LTD.
Conditions
(from sponsor)		 Advanced Solid Tumors
Related terms Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Stomach Neoplasms
Enrollment 98 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov